SCHEMBL9764855

SCHEMBL9764855

O=CN(O)CC(c1csc2ccccc12)c1csc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.48
CYP2A6 P11509 3/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KCNH2 Q12809 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 1/20 0.38
TAAR1 Q96RJ0 1/20 0.37
HSD17B2 P37059 1/20 0.37
ERN1 O75460 2/20 0.36
MAPT P10636 2/20 0.36
CMA1 P23946 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764840 0.78 ALOX5 (0.60) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9
SCHEMBL9764812 0.78 ALOX5 (0.50) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9
SCHEMBL9764841 0.76 ALOX5 (0.54) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9
SCHEMBL9764875 0.76 ALOX5 (0.48) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9
SCHEMBL10593685 0.72 MAOB (0.41) HSD17B2HDAC3HDAC4HDAC1HDAC7
SCHEMBL10559634 0.70 ALOX5 (0.58) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9
SCHEMBL9764916 0.69 ALOX5 (0.70) ALOX5CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL4478674 0.68 ALOX5 (0.51) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9
SCHEMBL5826470 0.68 CYP2A6 (0.50) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9
SCHEMBL5826364 0.68 CYP2A6 (0.50) ALOX5CYP2A6CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed